1-8 of 8
aryldialkylphosphatase
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Paraoxonase 2 Enables Initiation of B-ALL By Subverting Metabolic Gatekeeper Functions

Lili Pan, MD, Chao Hong, PhD, Gang Xiao, PhD, Huimin Geng, PhD, Shaoyuan Wang, MD, Markus Müschen, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 746.
https://doi.org/10.1182/blood-2019-125171
Published: 2019
Journal Articles

Paraoxonase-2 regulates coagulation activation through endothelial tissue factor

Julia Ebert, Petra Wilgenbus, John F. Teiber, Kerstin Jurk, Kathrin Schwierczek, Mareike Döhrmann, Ning Xia, Huige Li, Lisa Spiecker, Wolfram Ruf, Sven Horke
Journal: Blood
Blood (2018) 131 (19): 2161–2172.
https://doi.org/10.1182/blood-2017-09-807040
Published: 2018
Includes: Supplemental data
Journal Articles

PON2 Exemplifies a Unique Dependency of B Cell Lineage ALL Cells on Detoxifying Lactonases

Gang Xiao, PhD, Chao Hong, PhD, Huimin Geng, PhD, Markus Muschen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 882.
https://doi.org/10.1182/blood.V130.Suppl_1.882.882
Published: 2017
Journal Articles

Paraoxonases 1 and 2 (PON1 and 2) Polymorphisms in Diffuse Large B-Cell Lymphoma (DLBCL): Correlation with Clinical Outcomes

Debora Levy, MSc, PhD, Diego Reis, Karolline Santana da Silva, MSc, Luis A P C Lage, MD MSc, PhD, Bruno Sini, Luciana M. F. Maseli, Vanderson Rocha, MD MSc, PhD Prof MD, Juliana Pereira, MD PhD Prof MD, Sergio P Bydlowski, MD MSc, PhD Prof MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5130.
https://doi.org/10.1182/blood.V130.Suppl_1.5130.5130
Published: 2017
Journal Articles

N-Glycoproteomic Landscape of Human Lymphoid Cancers Reveals Novel Biomarkers and Potential Therapeutic Targets

Delphine CM Rolland, Pharm D, PhD, Venkatesha Basrur, PhD, Yoon Kyung Jeon, MD PhD, Carla McNeil-Schwalm, MD, Damian Fermin, PhD, Kevin Conlon, MS, Chih-Chiang Tsou, PhD, Noah A Brown, MD, Dafydd G Thomas, MD PhD, Nathanael G. Bailey, MD, Gilbert S Omenn, MD PhD, Alexey I Nesvizhskii, PhD, Megan S Lim, MD PhD, Kojo SJ Elenitoba-Johnson, MD
Journal: Blood
Blood (2015) 126 (23): 697.
https://doi.org/10.1182/blood.V126.23.697.697
Published: 2015
Journal Articles

A Soft-Drug Histone Deacetylase Inhibitor for Cutaneous T-Cell Lymphoma.

James Bradner, MD, Edward Greenberg, B.S., Sridevi Ponduru, M.D., Vishal Patel, B.S., Stuart Schreiber, Ph.D., Benjamin Rich, Ph.D., Ralph Mazitschek, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 800.
https://doi.org/10.1182/blood.V110.11.800.800
Published: 2007
Journal Articles

Serum Proteomic Profiling and Study of Haptoglobin Polymorphisms in Patients with Chronic GVHD after Allogeneic Hematopoietic Stem Cell Transplantation.

Joseph P. McGuirk, DO, Ying Yan, MD, Hao Gang, PhD, Weijian Hou, PhD, Sunil Abhyankar, MD, Casey Williams, PharmD, Robert Belt, MD, Jianpa Ruan, MD, Weisi Yan, PhD, Jeffery Wieman, MD
Journal: Blood
Blood (2006) 108 (11): 2890.
https://doi.org/10.1182/blood.V108.11.2890.2890
Published: 2006
Journal Articles

Design and Characterization of a Novel, Reverse Prodrug Histone Deacetylase Inhibitor for Cutaneous T-Cell Lymphoma.

James E. Bradner, MD, Edward F. Greenberg, BS, Stuart L. Schreiber, PhD, Ralph Mazitschek, PhD
Journal: Blood
Blood (2006) 108 (11): 4759.
https://doi.org/10.1182/blood.V108.11.4759.4759
Published: 2006